Education
About Us
Working with TipRanks
Follow Us
Flagship Pioneering Inc. Insider Profile
4 Followers
Flagship Pioneering Inc., Ten Percent Owner at Omega Therapeutics, holds 3.81M shares in Omega Therapeutics (Ticker: OMGAQ).
Flagship Pioneering Inc. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Flagship Pioneering Inc.'s holdings
Insider Roles
Ten Percent Owner
Roles that Flagship Pioneering Inc. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 05, 2021 - Aug 05, 2022
Return:-70.30%
The most profitable trade made by Flagship Pioneering Inc.
Flagship Pioneering Inc.'s Trading History
List of latest transactions for each holding click on a transaction to see Flagship Pioneering Inc.'s performance on stock
You May Also Like
Flagship Pioneering Inc. insider profile FAQ
What is the percentage of profitable transactions made by Flagship Pioneering Inc.?
The percentage of profitable transactions made by Flagship Pioneering Inc. is ―.
What is the average return per transaction made by Flagship Pioneering Inc.?
The average return per transaction made by Flagship Pioneering Inc. is ―.
What stocks does Flagship Pioneering Inc. hold?
Flagship Pioneering Inc. holds: OMGAQ stocks.
What was Flagship Pioneering Inc.’s latest transaction?
Flagship Pioneering Inc. latest transaction was an Uninformative Buy of ―.
What was Flagship Pioneering Inc.'s most profitable transaction?
Flagship Pioneering Inc.’s most profitable transaction was an Informative Buy of OMGAQ stock on August 5, 2021. The return on the trade was -70.30%.
What is Flagship Pioneering Inc.'s role in Omega Therapeutics?
Flagship Pioneering Inc.'s role in Omega Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.